Angiotensinogen gene haplotype is associated with the prevalence of Japanese non-alcoholic steatohepatitis

Hepatology Research

Volumn 41, Issue 12, 2011, Pages 1223-1229

  Ono, Masafumi ^a   Ochi, Tsunehiro ^a   Munekage, Kensuke ^a   Ogasawara, Mitsunari ^a   Hirose, Akira ^a   Nozaki, Yasuko ^a   Takahashi, Masaya ^a   Okamoto, Nobuto ^a   Saibara, Toshiji ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Angiotensinogen gene haplotype; Non alcoholic steatohepatitis; Single nucleotide polymorphisms

Indexed keywords

ANGIOTENSINOGEN;

ADULT; ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN TISSUE; HYPERTENSION; JAPANESE; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 82255185606     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2011.00883.x     Document Type: Article

References (39)

1. Valenti L, Fracanzani AL, Dongiovanni P etal. Tumor necrosis factor alpha promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease. Gastroenterology 2002; 122: 274-80.
2. Romeo S, Kozlitina J, Xing C etal. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 2008; 40: 1461-5.
3. Nozaki Y, Saibara T, Nemoto Y etal. Polymorphisms of interleukin 1-beta and beta-3-adrenergic receptor in Japanese patients with nonalcoholic steatohepatitis. Alcohol Clin Exp Res 2005; 28: 106S-110S.
4. Dong H, Wang J, Li C etal. The phosphatidylethanolamine N-methyltransferase gene V175M single nucleotide polymorphism confers the susceptibility to NASH in Japanese population. J Hepatol 2007; 46: 915-20.
5. Namikawa C, Zhang S-P, Vyselaar JR etal. Polymorphisms in microsomal triglyceride transfer protein gene and manganese superoxide dismutase gene in Japanese patients with nonalcoholic steatohepatitis. J Hepatol 2004; 40: 781-6.
6. Marchesini G, Bugianesi E, Forlani G etal. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003; 37: 917-23.
7. Yoshiji H, Kuriyama S, Yoshii J etal. Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats. Hepatology 2001; 34: 745-50.
8. Yokohama S, Yoneda M, Haneda M etal. Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis. Hepatology 2004; 40: 1222-5.
9. Hirose A, Ono M, Saibara T etal. Angiotensin II type 1 receptor blocker inhibits fibrosis in rat nonalcoholic steatohepatitis. Hepatology 2007; 45: 1375-81.
10. Iso H, Harada S, Shimamoto T etal. Angiotensinogen T174M and M235T variants, sodium intake and hypertension among non-drinking, lean Japanese men and women. J Hypertens 2000; 18: 1197-206.
11. Jeunemaitre X, Gimenez-Roqueplo AP, Celerier J etal. Angiotensinogen variants and human hypertension. Curr Hypertens Rep 1999; 1: 31-41.
12. Pereira AC, Mota GF, Cunha RS etal. Angiotensinogen 235T allele "dosage" is associated with blood pressure phenotypes. Hypertension 2003; 41: 25-30.
13. Staessen JA, Kuznetsova T, Wang JG etal. M235T angiotensinogen gene polymorphism and cardiovascular renal risk. J Hypertens 1999; 17: 9-17.
14. Tiago AD, Samani NJ, Candy GP etal. Angiotensinogen gene promoter region variant modifies body size-ambulatory blood pressure relations in hypertension. Circulation 2002; 106: 1483-7.
15. Wu SJ, Chiang FT, Chen WJ etal. Three single-nucleotide polymorphisms of the angiotensinogen gene and susceptibility to hypertension: single locus genotype vs. haplotype analysis. Physiol Genomics 2004; 17: 79-86.
16. Jeng JR. Left ventricular mass, carotid wall thickness, and angiotensinogen gene polymorphism in patients with hypertension. Am J Hypertens 1999; 12: 443-50.
17. Schmidt R, Schmidt H, Fazekas F etal. Angiotensinogen polymorphism M235T, carotid atherosclerosis, and small-vessel disease-related cerebral abnormalities. Hypertension 2001; 38: 110-15.
18. Su X, Lee L, Li X etal. Association between angiotensinogen, angiotensin II receptor genes, and blood pressure response to an angiotensin-converting enzyme inhibitor. Circulation 2007; 115: 725-32.
19. Kleiner DE, Brunt EM, Van Natta M etal. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41: 1313-21.
20. Brunt EM. Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis 2001; 21: 3-16.
21. Tsai CT, Fallin D, Chiang FT etal. Angiotensinogen gene haplotype and hypertension: interaction with ACE gene I allele. Hypertension 2003; 41: 9-15.
22. Rasmussen-Torvik LJ, North KE, Gu CC etal. A population association study of angiotensinogen polymorphisms and haplotypes with left ventricular phenotypes. Hypertension 2005; 46: 1294-9.
23. Goodarzi MO, Guo X, Taylor KD etal. Determination and use of haplotypes: ethnic comparison and association of the lipoprotein lipase gene and coronary artery disease in Mexican-Americans. Genet Med 2003; 5: 322-7.
24. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68: 978-89.
25. Tsai CT, Hwang JJ, Ritchie MD etal. Renin-angiotensin system gene polymorphisms and coronary artery disease in a large angiographic cohort: detection of high order gene-gene interaction. Atherosclerosis 2007; 195: 172-80.
26. Tokushige K, Takakura M, Tsuchiya-Matsushita N etal. Influence of TNF gene polymorphisms in Japanese patients with NASH and simple steatosis. J Hepatol 2007; 46: 1104-10.
27. Jeunemaitre X, Inoue I, Williams C etal. Haplotypes of angiotensinogen in essential hypertension. Am J Hum Genet 1997; 60: 1448-60.
28. Sato N, Katsuya T, Nakagawa T etal. Nine polymorphisms of angiotensinogen gene in the susceptibility to essential hypertension. Life Sci 2000; 68: 259-72.
29. Karjalainen J, Kujala UM, Stolt A etal. Angiotensinogen gene M235T polymorphism predicts left ventricular hypertrophy in endurance athletes. J Am Coll Cardiol 1999; 34: 494-9.
30. Iwai N, Shimoike H, Ohmichi N etal. Angiotensinogen gene and blood pressure in the Japanese population. Hypertension 1995; 25: 688-93.
31. Mehri S, Mahjoub S, Farhati A etal. Angiotensinogen gene polymorphism in acute myocardial infarction patients. J Renin Angiotensin Aldosterone Syst 2010; 12: 42-7.
32. Olivieri O, Stranieri C, Girelli D etal. Homozygosity for angiotensinogen 235T variant increases the risk of myocardial infarction in patients with multi-vessel coronary artery disease. J Hypertens 2001; 19: 879-84.
33. Katsuya T, Koike G, Yee TW etal. Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. Lancet 1995; 345: 1600-3.
34. Wang QS, Li YG, Chen XD etal. Angiotensinogen polymorphisms and acquired atrial fibrillation in Chinese. J Electrocardiol 2010; 43: 373-7.
35. Yoneda M, Hotta K, Nozaki Y etal. Association between angiotensin II type 1 receptor polymorphisms and the occurrence of nonalcoholic fatty liver disease. Liver Int 2009; 29: 1078-85.
36. Mehri S, Koubaa N, Hammami S etal. Genotypic interactions of renin-angiotensin system genes with diabetes type 2 in a Tunisian population. Life Sci 2010; 87: 49-54.
37. Anbazhagan K, Sampathkumar K, Ramakrishnan M etal. Analysis of polymorphism in renin angiotensin system and other related genes in South Indian chronic kidney disease patients. Clin Chim Acta 2009; 406: 108-12.
38. Molina-Molina M, Xaubet A, Li X etal. Angiotensinogen gene G-6A polymorphism influences idiopathic pulmonary fibrosis disease progression. Eur Respir J 2008; 32: 1004-8.
39. Mendizábal-Ruiz AP, Morales JA, Castro Marti Nez X etal. RAS polymorphisms in cancerous and benign breast tissue. J Renin Angiotensin Aldosterone Syst 2011; 12: 85-92.